OXAZOLIDINONE-QUINOLONE-HYBRID ANTIBIOTICS Russian patent published in 2009 - IPC C07D471/04 C07D413/10 C07D413/12 C07D413/14 C07D498/06 C07F9/553 C07F9/59 A61K31/422 A61K31/435 A61K31/4375 A61K31/4353 A61P31/00 A61P31/04 

Abstract RU 2371443 C2

FIELD: chemistry.

SUBSTANCE: invention relates to formula (I), compounds, , their pharmacologically acceptable salt, solvate and hydrate, where A is an alkylene group, alkenyl group, alkynyl group, heteroalkylene group, cycloalkylene group, heterocylcoalkylene group, arylene group or heteroarylene group, where each of the said groups can be substituted, Q is CR4, X is CR7 or N, Y is CR6 or N, n equals 1, 2 or 3, m equals 1, 2 or 3, R1 is H, F, Cl, Br, I, OH, NH2, alkyl group or heteroalkyl group, R is H, F or Cl, R3 is H, alkyl group, alkenyl group, alkynyl group, heteroalkyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkylaryl group or heteroarylalkyl group, where each of the said groups can be substituted with one, two or more halogen atoms or amino groups, R4 is hydroxy, a group with formula OPO3R92 or OSO3R10 or a heteroalkyl group, containing at least one OH, NH2, SO3R10, PO3R92 or COOH group or ester group of natural amino acid or its derivative, where R9 groups independently represent H, alkyl, cycloalkyl, aryl or aralkyl, and R10 is H, alkyl, cycloalkyl, aryl or aralkyl, and further values of R5, R6, R7 and R8 are given in the formula of invention. The invention also relates to pharmaceutical compositions with antibacterial activity, containing compounds described above, as well as to use of formula (I) compounds and a pharmaceutical composition for treating bacterial infection.

EFFECT: new compounds are obtained and described, which can be used as antibacterial agents and which are effective against multi-drug resistant bacteria.

18 cl, 32 ex

Similar patents RU2371443C2

Title Year Author Number
APPLICATION OF OXOZALIDINON-CHYNOLYN HYBRID ANTIBIOTICS FOR TREATMENT OF ANTHRAX AND OTHER INFECTIONS 2004
  • Khubshverlen Kristian
  • Speklen Zhan-Ljuk
  • Behshlin Daniel' K.
  • Lokher Khans
  • Zigval'T Kristin
RU2351335C2
INTERMEDIATE PRODUCTS FOR PRODUCING OXAZOLIDINONE AND QUINOLONE DERIVATIVES 2004
  • Khubshverlen Kristian
  • Speklen Zhan-Ljuk
  • Surive Zhan-Filipp
  • Behshlin Daniel' K.
RU2373203C2
COMBINED THERAPEUTIC AGENTS CONTAINING OXAZOLIDINONES-QUINOLONES INTENDED FOR TREATMENT OF BACTERIAL INFECTIONS 2014
  • Kapsner Tomas
  • Dalkhof Aksel
RU2675847C2
HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES 2014
  • Kapsner Tomas
  • Dalkhof Aksel
  • Gramatte Tomas
RU2702364C2
5-HYDROXYMETHYLOXAZOLIDIN-2-ONE DERIVATIVES 2007
  • Khubshverlen Kristian
  • Pansho Filipp
  • Speklen Zhan-Ljuk
RU2453546C2
THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY 2014
  • Yuj Tszyan
  • U Goshen
  • Yuen Po-Vaj
  • Villemur Eliziya
  • Shvarts Yakob
  • Li Kuon
  • Sellers Bendzhamin
  • Volgraf Metyu
RU2703273C2
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS 2012
  • Shudok Manfred
  • Vagner Mikhel
  • Bauer Armin
  • Kolmann Anna
RU2621695C2
SPIROCYCLIC NITRILES AS PROTEASE INHIBITORS 2007
  • Shudok Manfred
  • Vagner Mikhel'
  • Bauer Armin
  • Kol'Mann Anna
RU2478620C2
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES 2009
  • Ding Charl'Z Z.
  • Lu Gehn'Ljan
  • Kombrink Kit
  • Chehn' Djan'Tszjun'
  • Song Minzoo
  • Van Tszjan'Chehn
  • Ma Zhenkun
  • Palmer Brajan Desmond
  • Blejzer Ehdrian
  • Tompson Ehndrju M.
  • Kmentova Iveta
  • Saterlehnd Khamish Skott
  • Denni Uill'Jam Aleksandr
RU2504547C2
TLR7 AGONISTS 2019
  • Webber, Stephen, E.
  • Appleman, James, Richard
RU2817014C2

RU 2 371 443 C2

Authors

Jubshverlen Kristian

Speklen Zh. L.

Behshlin Daniel' Kaspar

Shmitt Kristin

Mjuller Shtefan

Kappi Mikhaehl'

Dates

2009-10-27Published

2004-12-20Filed